FierceBiotech Names Repare Therapeutics as One of Its “Fierce 15” Biotech Companies of 2017

FierceBiotech Names Repare Therapeutics as One of Its “Fierce 15” Biotech Companies of 2017   September 26, 2017 MONTREAL, Quebec and CAMBRIDGE, Mass – Repare Therapeutics today announced that it has been named by FierceBiotech as one of 2017’s Fierce 15 biotechnology companies, designating it as one of the most promising private biotechnology companies in the industry.  …

Read more

Repare Therapeutics Raises US$68 Million Series A

Repare Therapeutics Raises US$68 Million Series A Novel cancer company founded by Versant Ventures   June 22, 2017, Montreal, Quebec and Cambridge, Mass.   Repare Therapeutics Inc. today announced a US$68 million Series A financing to advance its platform and pipeline of novel medicines that target genetically defined weaknesses of cancers. Founding investor Versant Ventures…

Read more